Loading clinical trials...
Loading clinical trials...
Effect of Direct Rapid Antibiotic Susceptibility Testing (dRAST) on Treatment for Bacteremia in Patients With Hematologic Diseases: Randomized Controlled Trial
Conditions
Interventions
dRAST
Current standard method
Locations
1
South Korea
Seoul National University Hospital
Seoul, South Korea
Start Date
September 1, 2018
Primary Completion Date
September 15, 2019
Completion Date
October 10, 2019
Last Updated
October 14, 2019
NCT06795815
NCT06222164
NCT05794880
NCT06187831
NCT05196789
NCT06271252
Lead Sponsor
Seoul National University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions